Heart Failure Clinical Trial

Evaluation of Vepoloxamer in Chronic Heart Failure

Summary

The purpose of this study is to evaluate whether vepoloxamer can provide a blood chemical marker and functional benefit to damaged heart muscle cells. This will be evaluated by measurement of blood-based laboratory markers, exercise tolerance, and echocardiograms. In addition, the safety and blood levels of vepoloxamer in subjects with chronic heart failure will be evaluated.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Age 18 through 74
Duration of documented heart failure >3 months
On stable concomitant medication regimen ≥4 weeks
Left ventricular ejection fraction ≤35%
Systolic blood pressure ≥90 mmHg

Exclusion Criteria:

Severe valvular stenosis or primary valvular regurgitation as the cause of heart failure
History of myocardial infarction, coronary artery bypass graft surgery, or percutaneous intervention within the prior 3 months
Estimated glomerular filtration rate ≤45 mL/min/1.73 m2
Acutely decompensated heart failure within 1 month prior to the screening visit

Study is for people with:

Heart Failure

Phase:

Phase 2

Estimated Enrollment:

10

Study ID:

NCT02596477

Recruitment Status:

Terminated

Sponsor:

Mast Therapeutics, Inc.

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 3 Locations for this study

See Locations Near You

Research Center
Detroit Michigan, 48202, United States
Research Center
Tupelo Mississippi, 38801, United States
Research Center
Cardiff New South Wales, 2285, Australia
Research Center
Melbourne Victoria, , Australia

How clear is this clinincal trial information?

Study is for people with:

Heart Failure

Phase:

Phase 2

Estimated Enrollment:

10

Study ID:

NCT02596477

Recruitment Status:

Terminated

Sponsor:


Mast Therapeutics, Inc.

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider